• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 5070 Citations
  • 37 h-Index
20072019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jennifer Litton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Breast Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

10 Citations (Scopus)

Current Landscape of Immunotherapy in Breast Cancer: A Review

Adams, S., Gatti-Mays, M. E., Kalinsky, K., Korde, L. A., Sharon, E., Amiri-Kordestani, L., Bear, H., McArthur, H. L., Frank, E., Perlmutter, J., Page, D. B., Vincent, B., Hayes, J. F., Gulley, J. L., Litton, J., Hortobagyi, G. N., Chia, S., Krop, I., White, J., Sparano, J. & 2 others, Disis, M. L. & Mittendorf, E. A., Aug 1 2019, In : JAMA Oncology. 5, 8, p. 1205-1214 10 p.

Research output: Contribution to journalReview article

Immunotherapy
Breast Neoplasms
Active Immunotherapy
Tumor Microenvironment
Secondary Prevention

Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors

Clifton, G. T., Peace, K. M., Holmes, J. P., Vreeland, T. J., Hale, D. F., Herbert, G. S., Litton, J., Murthy, R. K., Lukas, J., Peoples, G. E. & Mittendorf Elizabeth, A., Apr 1 2019, In : Clinical Immunology. 201, p. 48-54 7 p.

Research output: Contribution to journalArticle

Granulocyte-Macrophage Colony-Stimulating Factor
Breast Neoplasms
Safety
Recurrence
Neoplasms
1 Citation (Scopus)
Breast Neoplasms
Triple Negative Breast Neoplasms
Poly(ADP-ribose) Polymerases
Therapeutics
Research Personnel
1 Citation (Scopus)

Progression-free survival (PFS) and toxicities of palbociclib in a geriatric population

Clifton, K., Min, Y., Kimmel, J., Litton, J., Tripathy, D. & Karuturi, M. S., Jun 30 2019, In : Breast Cancer Research and Treatment. 175, 3, p. 667-674 8 p.

Research output: Contribution to journalArticle

Geriatrics
Disease-Free Survival
Population
Nonparametric Statistics
palbociclib
9 Citations (Scopus)

Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations

Clifton, K., Gutierrez-Barrera, A., Ma, J., Bassett, R., Litton, J., Kuerer, H. M., Moulder, S., Albarracin, C., Hortobagyi, G. & Arun, B. K., Jul 1 2018, In : Breast Cancer Research and Treatment. 170, 1, p. 101-109 9 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Drug Therapy
Mutation
Survival
Disease-Free Survival